CCMQCAS# 132623-44-0 |
2D Structure
- CCG-63802
Catalog No.:BCC1460
CAS No.:620112-78-9
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 132623-44-0 | SDF | Download SDF |
PubChem ID | 3337816 | Appearance | Powder |
Formula | C12H9NO4 | M.Wt | 231.21 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 100 mM in DMSO and to 100 mM in 1eq. NaOH with gentle warming | ||
Chemical Name | 3-(carboxymethyl)quinoline-2-carboxylic acid | ||
SMILES | C1=CC=C2C(=C1)C=C(C(=N2)C(=O)O)CC(=O)O | ||
Standard InChIKey | IFXJDEHFADWURH-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C12H9NO4/c14-10(15)6-8-5-7-3-1-2-4-9(7)13-11(8)12(16)17/h1-5H,6H2,(H,14,15)(H,16,17) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | For use in conjunction with [3H]-homoquinolinic acid to characterize NR2B-containing NMDA receptors; selectively inhibits [3H]-homoquinolinic acid binding to non-NMDA sensitive sites. |
CCMQ Dilution Calculator
CCMQ Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.3251 mL | 21.6254 mL | 43.2507 mL | 86.5014 mL | 108.1268 mL |
5 mM | 0.865 mL | 4.3251 mL | 8.6501 mL | 17.3003 mL | 21.6254 mL |
10 mM | 0.4325 mL | 2.1625 mL | 4.3251 mL | 8.6501 mL | 10.8127 mL |
50 mM | 0.0865 mL | 0.4325 mL | 0.865 mL | 1.73 mL | 2.1625 mL |
100 mM | 0.0433 mL | 0.2163 mL | 0.4325 mL | 0.865 mL | 1.0813 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Bruceanic acid C
Catalog No.:BCN7999
CAS No.:132587-60-1
- 15-Demethylplumieride
Catalog No.:BCN6176
CAS No.:132586-69-7
- Olanzapine
Catalog No.:BCC5042
CAS No.:132539-06-1
- (Z)-Pugnac
Catalog No.:BCC5333
CAS No.:132489-69-1
- 2-TEDC
Catalog No.:BCC6735
CAS No.:132465-10-2
- Alosetron-d3 Hydrochloride
Catalog No.:BCC1345
CAS No.:1189919-71-8
- Neohesperidin
Catalog No.:BCN5915
CAS No.:13241-33-3
- Neoeriocitrin
Catalog No.:BCN3271
CAS No.:13241-32-2
- Chrysophanol 8-O-glucoside
Catalog No.:BCN6175
CAS No.:13241-28-6
- β-D-Glucopyranoside,(3β,6α,16β,20R,24S)-3-[(3,4-di-O-acetyl-β-D-xylopyranosyl)oxy]-20, 24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl
Catalog No.:BCC8370
CAS No.:1324005-51-7
- TC-G 1006
Catalog No.:BCC6277
CAS No.:1324003-64-6
- Boc-Gln(Trt)-OH
Catalog No.:BCC3384
CAS No.:132388-69-3
- Otophylloside O
Catalog No.:BCN7337
CAS No.:1326583-08-7
- Senecionine N-oxide
Catalog No.:BCN2130
CAS No.:13268-67-2
- Fmoc-Tle-OH
Catalog No.:BCC2657
CAS No.:132684-60-7
- [Leu31,Pro34]-Neuropeptide Y (human, rat)
Catalog No.:BCC5722
CAS No.:132699-73-1
- PyBrOP
Catalog No.:BCC2821
CAS No.:132705-51-2
- CP 96345
Catalog No.:BCC7509
CAS No.:132746-60-2
- Blonanserin
Catalog No.:BCC3740
CAS No.:132810-10-7
- YS-49
Catalog No.:BCC2067
CAS No.:132836-42-1
- Terchebulin
Catalog No.:BCN3264
CAS No.:132854-40-1
- PD 81723
Catalog No.:BCC7032
CAS No.:132861-87-1
- Lercanidipine hydrochloride
Catalog No.:BCC5238
CAS No.:132866-11-6
- HOE-S 785026
Catalog No.:BCC1633
CAS No.:132869-83-1
Association of traditional Chinese medicine body constitution and moderate-to-severe cancer-related fatigue in cancer patients.[Pubmed:30935553]
Complement Ther Med. 2019 Apr;43:44-48.
BACKGROUND AND PURPOSE: Fatigue is one of the most prevalent adverse events reported by cancer patients. The aim of this study was to investigate the association between traditional Chinese medicine body constitution (TCMBC) and moderate-to-severe cancer-related fatigue in cancer patients. MATERIALS AND METHODS: A cross-sectional study was conducted on cancer patients recruited from a regional hospital in southern Taiwan. The association between TCMBC, measured using the Constitution in Chinese Medicine Questionnaire (CCMQ) and moderate-to-severe cancer-related fatigue (based on the Taiwanese version of the Brief Fatigue Inventory score >/= 4) was evaluated using multiple logistic regression analysis. RESULTS: Of the 170 participants, 37 (21.8%) had moderate-to-severe fatigue. Yang-deficiency (adjusted odds ratio [aOR] = 3.55, 95% confidence interval [CI] = 1.50-8.40) and Qi-deficiency (aOR = 2.84, 95% CI = 1.18-6.82) TCMBC were significantly associated with moderate-to-severe cancer-related fatigue. CONCLUSION: TCMBC could be used as a clinical tool to identify cancer patients prone to experience moderate-to-severe cancer-related fatigue, and to provide Chinese medicine practitioners a basis for selecting an appropriate treatment approach based on TCMBC.
Identification of Traditional Chinese Medicine Constitutions and Physiological Indexes Risk Factors in Metabolic Syndrome: A Data Mining Approach.[Pubmed:30854002]
Evid Based Complement Alternat Med. 2019 Feb 3;2019:1686205.
Objective: In order to find the predictive indexes for metabolic syndrome (MS), a data mining method was used to identify significant physiological indexes and traditional Chinese medicine (TCM) constitutions. Methods: The annual health check-up data including physical examination data; biochemical tests and Constitution in Chinese Medicine Questionnaire (CCMQ) measurement data from 2014 to 2016 were screened according to the inclusion and exclusion criteria. A predictive matrix was established by the longitudinal data of three consecutive years. TreeNet machine learning algorithm was applied to build prediction model to uncover the dependence relationship between physiological indexes, TCM constitutions, and MS. Results: By model testing, the overall accuracy rate for prediction model by TreeNet was 73.23%. Top 12.31% individuals in test group (n=325) that have higher probability of having MS covered 23.68% MS patients, showing 0.92 times more risk of having MS than the general population. Importance of ranked top 15 was listed in descending order . The top 5 variables of great importance in MS prediction were TBIL difference between 2014 and 2015 (D_TBIL), TBIL in 2014 (TBIL 2014), LDL-C difference between 2014 and 2015 (D_LDL-C), CCMQ scores for balanced constitution in 2015 (balanced constitution 2015), and TCH in 2015 (TCH 2015). When D_TBIL was between 0 and 2, TBIL 2014 was between 10 and 15, D_LDL-C was above 19, balanced constitution 2015 was below 60, or TCH 2015 was above 5.7, the incidence of MS was higher. Furthermore, there were interactions between balanced constitution 2015 score and TBIL 2014 or D_LDL-C in MS prediction. Conclusion: Balanced constitution, TBIL, LDL-C, and TCH level can act as predictors for MS. The combination of TCM constitution and physiological indexes can give early warning to MS.
Management of IFN-beta-induced flu-like symptoms with Chinese herbal medicine in a patient with multiple sclerosis: A case report.[Pubmed:29458918]
Complement Ther Med. 2018 Feb;36:123-128.
OBJECTIVE: The purpose of this case report was to elucidate how Chinese herbal medicine (CHM) was used safely in this patient undergoing interferon beta (IFNbeta-1a) treatment and was associated with reduction in the side effects the patient had experienced when using IFNbeta-1a treatment alone. CLINICAL FEATURES AND OUTCOME: A 30-year-old man was diagnosed with MS in December 2014. For two years, he suffered from severe flu-like symptoms as side effects of IFNbeta-1a treatment. He subsequently received treatment with Chinese herbal medicine. During a two-month period of treatment with CHM, the patient responded well, with most of the symptoms induced by IFNbeta-1a ameliorated. The fever subsided. Incidence rates of dizziness and headaches were reduced. The health condition compared to the prior year increased by 50%. According to CCMQ and SF-36 assessments, CHM had the beneficial effects of recovering the yin-yang balance, harmonizing the qi, and regulating the blood state; essentially, improving the patient's comfort level and quality of life. CONCLUSIONS: IFNbeta-1a injections will damage qi and cause blood stasis in MS patients, thereby causing various side effects and weakening the body's immune system. Bu-Zhong-Yi-Qi-Tang, associated with Salvia miltiorrhiza, Ligusticum chuanxiong, Angelica dahurica and Polygonum multiflorum Thunb., is an effective prescription to ameliorate such symptoms and signs in patients with MS.
Correlation between tobacco and alcohol use and Traditional Chinese Medicine constitutions: an analysis based on a sample from general population of China.[Pubmed:24660589]
J Tradit Chin Med. 2013 Oct;33(5):642-6.
OBJECTIVE: To investigate the relationship between smoking and drinking and constitution types from Traditional Chinese Medicine (TCM) theory. METHODS: The Constitution in Chinese Medicine Questionnaire (CCMQ) was used. A sample of 8448 subjects from nine provinces and municipalities was chosen from the database of the TCM constitution and health status survey. Constituent ratio and correspondence analysis were used to find the relationship between smoking and drinking and TCM constitution. RESULTS: There was an association between smoking and drinking and the Gentleness, phlegm-dampness, and dampness-heat type constitutions. People that did not smoke tobacco or drink alcohol tended to have Yang-deficiency, Yin-deficiency, Qi-depression, Qi-deficiency, special diathesis, or blood-stasis type constitutions. CONCLUSION: There was a significant correlation between tobacco and alcohol use and TCM constitutions. To improve patient health, more attention should be paid to tobacco and alcohol control.
Validation of the constitution in chinese medicine questionnaire: does the traditional chinese medicine concept of body constitution exist?[Pubmed:23710222]
Evid Based Complement Alternat Med. 2013;2013:481491.
The study aims to adapt and validate the Constitution in Chinese Medicine Questionnaire (CCMQ) in Hong Kong Chinese people. 10 patients and 10 Chinese medicine practitioners (CMP) confirmed the content validity (CVI: 50%-100%) of CCMQ. 1084 HK subjects completed a cross-sectional study with 98.6% who could be classified into one or more BC types. Scaling success rates were 85.7%-100% for the 9 BC scales. Construct validity was supported by moderate correlations between CCMQ and SF-12v2 scores. The confirmatory factor analysis showed a reproducible structure as hypothesized. People with gentleness BC type had better health-related quality of life, HRQOL, than those with other (imbalanced) BC types. Internal consistency (reliability) (Cronbach's alpha > 0.6) and test-retest reliability were also satisfactory (ICC > 0.6) for all scales. However, the sensitivity and specificity in predicting the BC types diagnosed by CMP were only fair, ranging from 42.7% to 82.7%. 27.6% of subjects had a change from the imbalanced BC types to gentleness BC type after 6 months. The CCMQ was adapted for HK Chinese people and proved to be valid, reliable, and responsive. People classified to have imbalanced BC types had significantly lower HRQOL than gentleness BC type, which supported the validity and importance of the TCM concept of the physiological BC type.
Study on the relationship between Chinese medicine constitutive susceptibility and diversity of syndrome in diabetic nephropathy.[Pubmed:23576276]
Chin J Integr Med. 2013 Sep;19(9):656-62.
OBJECTIVE: To explore the relationship between Chinese medicine (CM) constitutive susceptibility and syndrome diversity in diabetic nephropathy (DN). METHODS: Epidemiologic investigation on constitution adopting the "Constitution in Chinese Medicine Questionnaire" (CCMQ), and survey on syndrome type by CM syndrome scale (preliminary) were carried out in 180 DN patients. Cluster analysis on symptom items was used to determine the syndrome type, and canonical correlation analysis was used to analyze the relationship between patients' constitution and syndrome. RESULTS: Baseline levels in all enrolled patients were not different statistically. Cluster analysis showed 8 syndromes existed in DN patients, namely: I, qi-yin deficiency with qi-stagnancy type; II, yin-yang deficiency with heat-water-blood stasis type; III, qi-yin deficiency with dampness-heat type; IV, yin-yang deficiency with blood-stasis and heat type; V, qi-yin deficiency with stagnant heat type; VI, yin-yang deficiency with inner dampness-heat stagnancy type; VII, yin deficiency with heat stagnancy type; and VIII, Kidney (Shen)-Spleen (Pi) deficiency with stagnant heat type. Correlation analysis on the 8 syndromes and the 9 constitutions showed statistical significant correlations between syndrome III and dampness-heat constitution (P=0.0001); syndrome IV and blood-stasis constitution (P=0.0001); and syndrome VII and yin-deficiency constitution (P=0.0180). CONCLUSION: Certain relationship revealed between CM constitutions and syndrome types; constitution decides the disease genesis, its syndrome type and prognosis, as well as the change of syndromes.
Association of Chinese medicine constitution susceptibility to diabetic nephropathy and transforming growth factor-beta1 (T869C) gene polymorphism.[Pubmed:21910069]
Chin J Integr Med. 2011 Sep;17(9):680-4.
OBJECTIVE: To explore the association of Chinese medicine constitution susceptibility to diabetic nephropathy (DN) and transforming growth factor (TGF)-beta1 (T869C) gene polymorphism. METHODS: TGF-beta1 gene polymorphism detected with polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was screened for 180 DN cases and 180 type 2 diabetic mellitus (T2DM) cases without combined DN. Patients with DN were surveyed epidemiologically with constitution in the Chinese medicine questionnaire (CCMQ). Binary logistic regression analysis was utilized to study the correlation between nine types of Chinese medicine constitution and TGF-beta1 (T869C) gene polymorphisms. RESULTS: The DN group has a higher frequency of TGF-beta1 (T869C) gene polymorphism than the T2DM group, and CC/CT genotypes than the T2DM group [CC, CT, TT (DN group): 88, 87, 5 (cases) versus (T2DM group) 71, 73, 36 (cases), P<0.05]. The phlegm-dampness constitution, damp-heat constitution, and blood stasis constitution have correlations with TGF-beta1 (T869C) gene polymorphism. CONCLUSION: Chinese medicine constitutions were associated with TGF-beta1 (T869C) gene polymorphism, a potential predictor of susceptibility to DN in T2DM patients.
[Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity].[Pubmed:21078265]
Zhong Xi Yi Jie He Xue Bao. 2010 Nov;8(11):1023-8.
OBJECTIVE: To explore the relationships between traditional Chinese medicine (TCM) constitutional types and overweight or obesity so as to provide evidence for adjusting constitutional bias and preventing and treating obesity. METHODS: The data comes from a cross-sectional survey on TCM constitution of 18 805 samples aged above 18 in Beijing and 8 provinces (Jiangsu, Anhui, Gansu, Qinghai, Fujian, Jilin, Jiangxi and Henan) in China. The survey of TCM constitution was performed by standardized constitution in Chinese medicine questionnaire (CCMQ). Discriminatory analysis method was used to judge the individual's constitutional type (gentleness type, qi-deficiency type, yang-deficiency type, yin-deficiency type, phlegm-dampness type, dampness-heat type, blood-stasis type, qi-depression type and special diathesis type). The relationships between TCM constitution types and overweight or obesity was investigated by logistic regression analysis. RESULTS: Compared with gentleness type, the risk of overweight (OR, 2.05; 95% CI, 1.79-2.35) and obesity (OR, 4.34; 95% CI, 3.52-5.36) in phlegm-dampness type is significantly increased; the risk of obesity (OR, 1.60; 95% CI, 1.30-1.98) in qi-deficiency type is significantly higher; the risk of overweight and obesity in yang-deficiency type, blood-stasis type, and qi-depression type is significantly lower. CONCLUSION: Phlegm-dampness type and qi-deficiency type are the main constitutional risk factors of overweight or obesity.
[3H]homoquinolinate binds to a subpopulation of NMDA receptors and to a novel binding site.[Pubmed:9751179]
J Neurochem. 1998 Oct;71(4):1464-70.
NMDA receptors mediate several important functions in the CNS; however, little is known about the pharmacology, biochemistry, and function of distinct NMDA receptor subtypes in brain tissue. To facilitate the study of native NMDA receptor subpopulations, we have determined the radioligand binding properties of [3H]homoquinolinate, a potential subtype-selective ligand. Using quantitative receptor autoradiography, NMDA-specific [3H]homoquinolinate binding selectively labeled brain regions expressing NR2B mRNA (layers I-III of cerebral cortex, striatum, hippocampus, and septum). NMDA-specific [3H]homoquinolinate binding was low in brain regions that express NR2C and NR2D mRNA (cerebellar granular cell layer, NR2C; glomerular layer of olfactory bulb, NR2C/NR2D; and midline thalamic nuclei, NR2D). In forebrain, the pattern of NMDA-specific [3H]homoquinolinate binding paralleled NR2B and not NR2A distribution. In addition to NMDA-displaceable binding, there was a subpopulation of [3H]homoquinolinate binding sites in the forebrain, cerebellum, and choroid plexus that was not displaced by NMDA or L-glutamate. In contrast, we found that the derivative of homoquinolinate, 2-carboxy-3-carboxymethylquinoline, markedly inhibited the NMDA-insensitive binding of [3H]homoquinolinate without inhibiting the NMDA-sensitive population. [3H]Homoquinolinate may be useful for selectively characterizing NR2B-containing NMDA receptors in a preparation containing multiple receptor subtypes and for characterizing a novel binding site of unknown function.